Graham (10) showed that the prevalence of preexisting autoimmune disease and elevated ANA (antinuclear antibodies) in the cohort of participants with post-COVID-19 compared to the general population possibly pointing toward an autoimmune contribution (10). This evidence concerns the gene BTG3 and autoimmune disease.